Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-16

Clinical Trial Update: Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of topical rapamycin for chronic erosive oral lichen planus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapamycin (topical) (sirolimus)

Snippet

Sponsor: University Hospital, Tours | Conditions: Oral Lichen Planus | Phase 3 | Status: TERMINATED